Patient | Sex | Age | Primary tumor | cTNM | pTNM |
---|---|---|---|---|---|

1 | F | 57 | Oral cavity, tongue, right | T_{2}N_{0}M_{0} | T_{2}N_{1}M_{0} |

2 | M | 57 | Unknown primary, base of tongue right side suspected | T_{X}N_{2a}M_{0} | T_{is}N_{2b}M_{0} |

3 | F | 72 | Oropharynx, tonsil, right | T_{2}N_{2b}M_{0} | T_{2}N_{2b}M_{0} |

4 | F | 53 | Oropharynx, tonsil, right | T_{3}N_{0}M_{0} | T_{3}N_{2b}M_{0} |

5 | M | 63 | Oropharynx, tonsil, right | T_{4}N_{0}M_{0} | T_{4}N_{2b}M_{0} |

6 | F | 58 | Oral cavity, alveolar process and floor of mouth, left | T_{4}N_{0}M_{0} | T_{4}N_{2b}M_{0} |

7 | M | 54 | Oral cavity, tongue/floor of mouth, right | T_{3}N_{0}M_{0} | T_{3}N_{2b}M_{0} |

8 | M | 55 | Oropharynx, tonsil, left | T_{4}N_{2a}M_{0} | T_{4}N_{2b}M_{0} |

9 | F | 54 | Hypopharynx, piriform sinus, left | T_{4}N_{2b}M_{0} | T_{4}N_{2b}M_{0} |

10 | F | 65 | Oral cavity, base of tongue, right | T_{2}N_{0}M_{0} | T_{2}N_{0}M_{0} |

11 | M | 53 | Larynx, glottic | T_{4}N_{0}M_{0} | T_{4}N_{0}M_{0} |

12 | M | 59 | Larynx, supraglottic | T_{4}N_{0}M_{0} | T_{4}N_{0}M_{0} |

13 | F | 49 | Residual disease after T_{2}N_{0} tonsil carcinoma, left | NA | NA |

14 | M | 58 | Oropharynx, base of tongue, right | T_{2}N_{2b}M_{0} | T_{2}N_{2b}M_{0} |

15 | M | 48 | Oropharynx, tonsil, right | T_{3}N_{0}M_{0} | T_{3}N_{1}M_{0} |

16 | F | 63 | Oropharynx, tonsil, left | T_{3}N_{2b}M_{0} | T_{3}N_{2b/c}M_{0} |

17 | M | 53 | Oropharynx, tonsil, right | T_{2}N_{3}M_{0} | T_{2}N_{3}M_{0} |

18 | M | 58 | Larynx, supraglottic, recurrence | NA | NA |

19 | M | 71 | Oropharynx, soft palate, right | T_{3}N_{2c}M_{0} | T_{2}N_{2c}M_{0} |

20 | M | 60 | Larynx, supraglottic, recurrence | NA | NA |

Abbreviations: TNM, tumor-node-metastasis system; cTNM, clinical classification; pTNM, pathologic classification; NA, not applicable.